104 related articles for article (PubMed ID: 16967811)
1. Diabetic neuropathy and zinc therapy.
Hayee MA; Mohammad QD; Haque A
Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):62-7. PubMed ID: 16967811
[TBL] [Abstract][Full Text] [Related]
2. Oral zinc therapy in diabetic neuropathy.
Gupta R; Garg VK; Mathur DK; Goyal RK
J Assoc Physicians India; 1998 Nov; 46(11):939-42. PubMed ID: 11229219
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone.
Sharquie KE; Najim RA; Al-Hayani RK; Al-Nuaimy AA; Maroof DM
Saudi Med J; 2008 May; 29(5):734-8. PubMed ID: 18454224
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
Faghihi G; Iraji F; Shahingohar A; Saidat A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
[TBL] [Abstract][Full Text] [Related]
5. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study.
Sharquie KE; Najim RA; Al-Salman HN
Int J Dermatol; 2006 Jul; 45(7):857-61. PubMed ID: 16863527
[TBL] [Abstract][Full Text] [Related]
6. Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study.
Sharquie KE; Najim RA; Al-Dori WS; Al-Hayani RK
J Dermatol; 2006 Aug; 33(8):541-6. PubMed ID: 16923135
[TBL] [Abstract][Full Text] [Related]
7. Initiation of zinc treatment for acute childhood diarrhoea and risk for vomiting or regurgitation: a randomized, double-blind, placebo-controlled trial.
Larson CP; Hoque AB; Larson CP; Khan AM; Saha UR
J Health Popul Nutr; 2005 Dec; 23(4):311-9. PubMed ID: 16599101
[TBL] [Abstract][Full Text] [Related]
8. Topical zinc sulphate solution for treatment of viral warts.
Sharquie KE; Khorsheed AA; Al-Nuaimy AA
Saudi Med J; 2007 Sep; 28(9):1418-21. PubMed ID: 17768472
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea.
Bamford JT; Gessert CE; Haller IV; Kruger K; Johnson BP
Int J Dermatol; 2012 Apr; 51(4):459-62. PubMed ID: 22435439
[TBL] [Abstract][Full Text] [Related]
10. Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris device.
Forst T; Nguyen M; Forst S; Disselhoff B; Pohlmann T; Pfützner A
Diabetes Nutr Metab; 2004 Jun; 17(3):163-8. PubMed ID: 15334794
[TBL] [Abstract][Full Text] [Related]
11. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
Halyard MY; Jatoi A; Sloan JA; Bearden JD; Vora SA; Atherton PJ; Perez EA; Soori G; Zalduendo AC; Zhu A; Stella PJ; Loprinzi CL
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1318-22. PubMed ID: 17394940
[TBL] [Abstract][Full Text] [Related]
12. [A zinc sulfate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesions by Human Papillomavirus].
Scirpa P; Scambia G; Masciullo V; Battaglia F; Foti E; Lopez R; Villa P; Malecore M; Mancuso S
Minerva Ginecol; 1999 Jun; 51(6):255-60. PubMed ID: 10479878
[TBL] [Abstract][Full Text] [Related]
13. [Acupuncture for distal symmetric multiple peripheral neuropathy of diabetes mellitus: a randomized controlled trial].
Lu M; Li K; Wang J
Zhongguo Zhen Jiu; 2016 May; 36(5):481-4. PubMed ID: 27509606
[TBL] [Abstract][Full Text] [Related]
14. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial.
Firooz A; Khatami A; Khamesipour A; Nassiri-Kashani M; Behnia F; Nilforoushzadeh M; Pazoki-Toroudi H; Dowlati Y
J Drugs Dermatol; 2005; 4(1):73-9. PubMed ID: 15696988
[TBL] [Abstract][Full Text] [Related]
15. Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation.
Farvid MS; Homayouni F; Amiri Z; Adelmanesh F
Diabetes Res Clin Pract; 2011 Jul; 93(1):86-94. PubMed ID: 21496936
[TBL] [Abstract][Full Text] [Related]
16. Oral malodor reduction from a zinc-containing toothpaste.
Navada R; Kumari H; Le S; Zhang J
J Clin Dent; 2008; 19(2):69-73. PubMed ID: 18763690
[TBL] [Abstract][Full Text] [Related]
17. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
Han LP; Yu DM; Xie Y
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2513-5. PubMed ID: 19080636
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
20. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
